차세대 시퀀싱 시장 : 예측(2025-2030년)

Next Generation Sequencing Market Size:

The next generation sequencing market is expected to grow from USD 16.696 billion in 2025 to USD 36.778 billion in 2030, at a CAGR of 17.11%.

Next-generation sequencing (NGS) represents a transformative parallel sequencing technology that delivers exceptional scalability, speed, and ultra-high throughput capabilities. This advanced technology determines nucleotide sequences in complete genomes or targeted regions of RNA or DNA, fundamentally modernizing biological sciences and enabling laboratories to conduct diverse applications while studying biological systems across multiple levels.

Technology Capabilities and Advantages

NGS addresses the limitations of traditional DNA sequencing technologies by providing comprehensive solutions for complex genomics research. The technology enables rapid whole genome sequencing, deep sequencing of targeted regions, RNA sequencing (RNA-Seq) for discovering novel RNA variants and splice sites, and mRNA quantification for gene expression analysis. These capabilities position NGS as an essential tool for addressing advanced genomics questions that exceed the capacity of conventional sequencing methods.

The evolution of NGS platforms has introduced efficient, portable, and user-friendly systems capable of delivering rapid and accurate results. These technological improvements have enhanced accessibility and operational efficiency, contributing to widespread adoption across research and clinical applications.

Market Growth Drivers

Expanding Application Scope

The increasing application of NGS across diverse research areas drives sustained market demand. Enhanced genome mapping programs and collaborative partnerships result in significant R&D investments, creating a robust foundation for market expansion. The versatility of NGS technology enables its deployment across multiple biological research domains, from basic research to clinical diagnostics.

Government and Private Sector Investment

Substantial investments from both government and private sectors in research and development programs support market growth, particularly in developing countries focused on advancing genetic research and disease understanding. Government organizations actively participate in sequencing programs to identify improved treatment approaches for cancer and other diseases. This support facilitates market entry for new participants and creates growth opportunities for established industry players.

The widespread governmental and private backing has led to increased adoption of NGS instruments and expanded utilization of required consumables, supporting overall market development across multiple geographic regions.

Technological Platform Advancement

Continuous technological improvements have resulted in more efficient, portable, and accessible NGS platforms. These advancements provide competitive advantages to prominent companies while encouraging research and development initiatives throughout the industry. The introduction of user-friendly systems with enhanced accuracy and speed capabilities has broadened the potential user base and application scenarios.

Market Constraints and Challenges

Skilled Personnel Limitations

The shortage of qualified professionals represents a significant market constraint. The limited availability of skilled personnel capable of interpreting complex NGS data creates bottlenecks in research progress and industry growth. This skills gap particularly affects developing nations where technical expertise may be less readily available, hindering technology adoption and effective utilization.

Research and Development Funding Challenges

Financial constraints in research and development, particularly in developing economies, present ongoing market challenges. Many research institutions and academic organizations face budget limitations that prevent acquisition of advanced, premium-priced NGS equipment and technologies. This funding dependency on external sources creates uncertainty and may limit market expansion in regions with constrained financial resources.

The interpretation of complex data generated by NGS platforms requires specialized expertise and significant time investment, creating operational challenges that may slow research progress and technology adoption rates.

Strategic Implications

The NGS market demonstrates strong growth potential driven by expanding applications, government support, and technological advancement. However, success requires addressing skilled personnel limitations through comprehensive training programs and technology simplification initiatives. Market participants must balance advanced capability development with accessibility considerations to maximize adoption across diverse research environments and geographic regions while supporting the development of local expertise and infrastructure.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Next Generation Sequencing Market Segments:

By Offerings

• Hardware
• Software & Services

By Type

• Genome Sequencing
• Exome Sequencing
• Targeted Sequencing

By Method

• Sequencing By Synthesis (SBS)
• Ion Semiconductor Sequencing
• Nanopore Sequencing
• Others

By Application

• Oncology
• Infectious Disease Diagnostics
• Drug Discovery & Development
• Others

By End-Users

• Hospitals & Clinics
• Academic & Research Institutes
• Pharmaceutical & Biotech Companies
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEXT GENERATION SEQUENCING MARKET BY OFFERINGS

• 5.1. Introduction
• 5.2. Hardware
• 5.3. Software & Services

6. NEXT GENERATION SEQUENCING MARKET BY TYPE

• 6.1. Introduction
• 6.2. Genome Sequencing
• 6.3. Exome Sequencing
• 6.4. Targeted Sequencing

7. NEXT GENERATION SEQUENCING MARKET BY METHOD

• 7.1. Introduction
• 7.2. Sequencing By Synthesis (SBS)
• 7.3. Ion Semiconductor Sequencing
• 7.4. Nanopore Sequencing
• 7.5. Others

8. NEXT GENERATION SEQUENCING MARKET BY APPLICATION

• 8.1. Introduction
• 8.2. Oncology
• 8.3. Infectious Disease Diagnostics
• 8.4. Drug Discovery & Development
• 8.5. Others

9. NEXT GENERATION SEQUENCING MARKET BY END-USERS

• 9.1. Introduction
• 9.2. Hospitals & Clincs
• 9.3. Academic & Research Institutes
• 9.4. Pharmaceutical & Biotech Companies
• 9.5. Others

10. NEXT GENERATION SEQUENCING MARKET BY GEOGRAPHY

• 10.1. Introduction
• 10.2. North America
  • 10.2.1. USA
  • 10.2.2. Canada
  • 10.2.3. Mexico
• 10.3. South America
  • 10.3.1. Brazil
  • 10.3.2. Argentina
  • 10.3.3. Others
• 10.4. Europe
  • 10.4.1. Germany
  • 10.4.2. France
  • 10.4.3. United Kingdom
  • 10.4.4. Spain
  • 10.4.5. Others
• 10.5. Middle East and Africa
  • 10.5.1. Saudi Arabia
  • 10.5.2. UAE
  • 10.5.3. Israel
  • 10.5.4. Others
• 10.6. Asia Pacific
  • 10.6.1. China
  • 10.6.2. India
  • 10.6.3. Japan
  • 10.6.4. South Korea
  • 10.6.5. Indonesia
  • 10.6.6. Thailand
  • 10.6.7. Taiwan
  • 10.6.8. Others

11. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 11.1. Major Players and Strategy Analysis
• 11.2. Market Share Analysis
• 11.3. Mergers, Acquisitions, Agreements, and Collaborations
• 11.4. Competitive Dashboard

12. COMPANY PROFILES

• 12.1. F. Hoffmann-La Roche AG
• 12.2. Agilent Technologies
• 12.3. Illumina, Inc.
• 12.4. Thermo Fisher Scientific.
• 12.5. Macrogen, Inc
• 12.6. BGI Group
• 12.7. Qiagen
• 12.8. DNASTAR
• 12.9. Pacific Biosciences of California, Inc.
• 12.10. Bio-Rad Laboratories, Inc.

13. APPENDIX

• 13.1. Currency
• 13.2. Assumptions
• 13.3. Base and Forecast Years Timeline
• 13.4. Key benefits for the stakeholders
• 13.5. Research Methodology
• 13.6. Abbreviations

LIST OF FIGURES

LIST OF TABLES